| Intestinal solute carriers: an overview of trends and strategies for improving oral drug absorption B Steffansen, CU Nielsen, B Brodin, AH Eriksson, R Andersen, S Frokjaer European journal of pharmaceutical sciences 21 (1), 3-16, 2004 | 219 | 2004 |
| Ivermectin excreted in cattle dung after subcutaneous injection or pour-on treatment: concentrations and impact on dung fauna C Sommer, B Steffansen, BO Nielsen, J Grønvold, KMV Jensen, ... Bulletin of Entomological Research 82 (2), 257-264, 1992 | 198 | 1992 |
| The novel oxygenated chalcone, 2, 4-dimethoxy-4'-butoxychalcone, exhibits potent activity against human malaria parasite Plasmodium falciparum in vitro and rodent parasites … M Chen, SB Christensen, L Zhai, MH Rasmussen, TG Theander, ... Journal of Infectious Diseases 176 (5), 1327-1333, 1997 | 184 | 1997 |
| Transport of peptidomimetic drugs by the intestinal di/tri‐peptide transporter, PepT1 B Brodin, CU Nielsen, B Steffansen, S Frøkjær Pharmacology & toxicology 90 (6), 285-296, 2002 | 157 | 2002 |
| Epidermal growth factor inhibits glycylsarcosine transport and hPepT1 expression in a human intestinal cell line CU Nielsen, J Amstrup, B Steffansen, S Frokjaer, B Brodin American Journal of Physiology-Gastrointestinal and Liver Physiology 281 (1 …, 2001 | 124 | 2001 |
| Dipeptide model prodrugs for the intestinal oligopeptide transporter. Affinity for and transport via hPepT1 in the human intestinal Caco-2 cell line CU Nielsen, R Andersen, B Brodin, S Frokjaer, ME Taub, B Steffansen Journal of Controlled Release 76 (1-2), 129-138, 2001 | 90 | 2001 |
| Passive diffusion of drug substances: the concepts of flux and permeability B Brodin, B Steffansen, CU Nielsen Molecular biopharmaceutics, 135-152, 2010 | 81 | 2010 |
| Changes with time after treatment in the concentrations of ivermectin in fresh cow dung and in cow pats aged in the field C Sommer, B Steffansen Veterinary Parasitology 48 (1-4), 67-73, 1993 | 74 | 1993 |
| Estimating intestinal absorption of inorganic and organic selenium compounds by in vitro flux and biotransformation studies in Caco-2 cells and ICP-MS detection B Gammelgaard, LH Rasmussen, C Gabel-Jensen, B Steffansen Biological trace element research 145, 248-256, 2012 | 64 | 2012 |
| Model prodrugs designed for the intestinal peptide transporter. A synthetic approach for coupling of hydroxy-containing compounds to dipeptides GM Friedrichsen, CU Nielsen, B Steffansen, M Begtrup European journal of pharmaceutical sciences 14 (1), 13-19, 2001 | 62 | 2001 |
| Human peptide transporters: therapeutic applications CU Nielsen, B Brodin, FS Jørgensen, S Frokjaer, B Steffansen Expert Opinion on Therapeutic Patents 12 (9), 1329-1350, 2002 | 59 | 2002 |
| Acyclovir prodrug for the intestinal di/tri-peptide transporter PEPT1: comparison of in vivo bioavailability in rats and transport in Caco-2 cells AE Thomsen, MS Christensen, MA Bagger, B Steffansen European journal of pharmaceutical sciences 23 (4-5), 319-325, 2004 | 54 | 2004 |
| Nonionic surfactants modulate the transport activity of ATP-binding cassette (ABC) transporters and solute carriers (SLC): Relevance to oral drug absorption AAA Al-Ali, RB Nielsen, B Steffansen, R Holm, CU Nielsen International journal of pharmaceutics 566, 410-433, 2019 | 50 | 2019 |
| Epidermal growth factor and insulin short‐term increase hPepT1‐mediated glycylsarcosine uptake in Caco‐2 cells CU Nielsen, J Amstrup, R Nielsen, B Steffansen, S Frokjaer, B Brodin Acta physiologica scandinavica 178 (2), 139-148, 2003 | 50 | 2003 |
| Delivery aspects of small peptides and substrates for peptide transporters B Steffansen, CU Nielsen, S Frokjaer European journal of pharmaceutics and biopharmaceutics 60 (2), 241-245, 2005 | 49 | 2005 |
| Phe-Gly dipeptidomimetics designed for the di-/tripeptide transporters PEPT1 and PEPT2: synthesis and biological investigations J Våbenø, T Lejon, CU Nielsen, B Steffansen, W Chen, H Ouyang, ... Journal of medicinal chemistry 47 (4), 1060-1069, 2004 | 49 | 2004 |
| In vitro metabolism and permeation studies in rat jejunum: organic chromium compared to inorganic chromium B Gammelgaard, K Jensen, B Steffansen Journal of trace elements in medicine and biology 13 (1-2), 82-88, 1999 | 49 | 1999 |
| Interaction between fed gastric media (Ensure Plus®) and different hypromellose based caffeine controlled release tablets: Comparison and mechanistic study of caffeine release … F Franek, P Holm, F Larsen, B Steffansen International Journal of Pharmaceutics 461 (1-2), 419-426, 2014 | 47 | 2014 |
| Novel wound models for characterizing ibuprofen release from foam dressings B Steffansen, SPK Herping International journal of pharmaceutics 364 (1), 150-155, 2008 | 45 | 2008 |
| Dipeptidomimetic ketomethylene isosteres as pro-moieties for drug transport via the human intestinal di-/tripeptide transporter hPEPT1: design, synthesis, stability, and … J Våbenø, CU Nielsen, T Ingebrigtsen, T Lejon, B Steffansen, K Luthman Journal of medicinal chemistry 47 (19), 4755-4765, 2004 | 44 | 2004 |
